Low-dose rituximab is poorly effective in patients with primary membranous nephropathy

Gabriella Moroni, Federica Depetri, Lucia Del Vecchio, Beniamina Gallelli, Francesca Raffiotta, Elisa Giglio, Francesca Brunini, Marco D'Amico, Selena Longhi, Antonella Radice, Piergiorgio Messa, Renato Alberto Sinico

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Low-dose rituximab is poorly effective in patients with primary membranous nephropathy'. Together they form a unique fingerprint.

Medicine & Life Sciences